Bioline Rx reported $2.22M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Bio Path USD 0 0 Mar/2025
Bioline Rx USD 2.22M 1.14M Jun/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025